Here are relevant reports on : lab-glassware-market
-
CVD Lab-grown Diamonds Market by Type (Rough, Polished), Color ( Colored, Colorless), Application (Machine & Cutting Tools; Heat Sinks & Exchangers; Optical, Laser, & X-ray; Electronics; Healthcare; Gemstone, Others), and Region - Global Forecast to 2027
The CVD lab-grown diamonds market is expected to grow from USD 11.3 billion in 2022 to USD 15.9 billion by 2027, at a CAGR of 7.1% during the forecast period. De Beers Group (UK), Sumitomo Electric Industries Ltd. (Japan), Goldiam (India), Adamas One Corp (US), Bhanderi Lab Grown Diamonds LLP (India), Hebei Plasma Diamond Technology Co., Ltd. (China), SP3 Diamond Technologies (US), Delaware Diamond Knives, Inc. (US), EDP Corporation (Japan), Tomei Diamond Corporation (Japan), Heyaru (Belgium), Beijing Worldia Diamond Tools Co., Ltd. (China), Ritani (US), and Shanghai Zhengshi Technology Co., Ltd. (China) are the key players in CVD lab-grown diamond market.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Europe Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Europe molecular diagnostics market, valued at US$5.60 billion in 2025, stood at US$6.05 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of US$10.15 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Molecular Infectious Disease Testing Market by Product & Service (Kits, Instruments), Type (Singleplex, Multiplex), Test Type (Lab, PoC), Disease (STD, Flu, GI, HAI), Technology (PCR, NGS), End User (Diagnostic Labs, Hospitals) - Global Forecast to 2029
The global molecular infectious disease testing market, valued at US$8.49B in 2023, is forecasted to grow at a 13.7% CAGR, reaching US$9.37B by 2024 and US$17.78B by 2029. Major drivers of market growth include rising burden of infectious diseases and rapid technological advancements in molecular diagnostics. The increased incidence of emerging infectious diseases and antibiotic-resistant infections leads to greater demand for accurate and reliable diagnostics.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Communication Test & Measurement Market by Type of Test (Enterprise Test, Field Network Test, Lab & Manufacturing Test, Network Assurance Test), by Test Solution (Wireless Test Solution and Wireline Test Solution) - Global Forecast to 2029
The communication test and measurement market size is projected to reach USD 14.9 billion by 2029, at a CAGR of 9.1% during the forecast period. The communication test and measurement market comprises major providers, such as Anritsu (Japan), Fortive (US), EXFO (Canada), Rohde & Schwarz (Germany), Emerson (US), VIAVI Solutions (US), Yokogawa (Japan), Spirent Communications (UK), Keysight Technologies (US), Huawei (China), Hammer (US), Calnex Solutions (UK), Luna Innovations (US), NetScout (US), Cisco (US), LitePoint (US), SysMech (England), VeEX (US), TEOCO Corporation (US), NetAlly (US), thinkRF (Canada), Kyrio (US), Fastech Telecommunications (India), Eagle Photonics (India), Verkotan (Finland). To increase their market share in the communication test and measurement industry, these competitors have used a variety of growth methods, including partnerships, agreements, collaborations, new product releases, product enhancements, and acquisitions.
- Published: April 2024
- Price: $ 7150
- TOC Available:
-
Asia Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Asia Pacific molecular diagnostics market, valued at US$3.85 billion in 2025, stood at US$4.22 billion in 2026 and is projected to advance at a resilient CAGR of 12.4% from 2026 to 2031, culminating in a forecasted valuation of US$7.58 billion by the end of the period. The Asia Pacific molecular diagnostics market is experiencing significant growth as healthcare systems across the region are increasingly focusing on enhancing the accuracy of diagnosis and increasing access to diagnostic testing.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, PCR, NGS), Disease (Hepatitis, HIV, HAI, TB, Flu, Syphilis), End User (Labs) - Global Forecast to 2030
The global infectious disease diagnostics market, valued at US$24.96 billion in 2024, stood at US$26.58 billion in 2025 and is projected to advance at a resilient CAGR of 9.7% from 2025 to 2030, culminating in a forecasted valuation of US$40.20 billion by the end of the period. The key growth drivers include the increasing prevalence of infectious diseases, the rising demand for early & accurate diagnosis, and continuous advancements in diagnostic technologies.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Hematology Analyzers and Reagents Market by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
The global hematology analyzers and reagents market, valued at US$5.9 billion in 2022, stood at US$6.6 billion in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$8.8 billion by the end of the period. Market growth in North America is driven by factors such as favorable research scenario and rising demand for blood and blood components
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Middle East & Africa molecular diagnostics market, valued at USD 0.32 billion in 2025, stood at USD 0.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of USD 0.47 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
High Throughput Screening Market / HTS Market by Offering (Instruments, Consumables (Reagents, Kits), Software, Services), Technology (Cell-based Assays, Lab-on-Chip, Label-free), Application (Drug Discovery, Life Sciences Research) - Global Forecast to 2029
The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to advance at a resilient CAGR of 11.8% from 2024 to 2029, culminating in a forecasted valuation of US$50.2 billion by the end of the period.Growth in this market is primarily driven by the growing adoption of open innovative models in pharmaceutical & biotechnology companies, & the growing availability of funds for research
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Latin America molecular diagnostics market, valued at US$0.72 billion in 2025, stood at US$0.76 billion in 2026 and is projected to advance at a resilient CAGR of 8.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.16 billion by the end of the period. This growth can be attributed to the rising demand for reliable diagnostic results, especially in infectious diseases & chronic illnesses like cancer.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
